Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt

por Thomas, Scott, Thurn, K. Ted, Raha, Paromita, Chen, Stephanie, Munster, Pamela N.
Publicado 2013

Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression

por Raha, Paromita, Thomas, Scott, Thurn, K Ted, Park, Jeenah, Munster, Pamela N
Publicado 2015

Nanoparticles for Applications in Cellular Imaging

por Thurn, K Ted, Brown, EricMB, Wu, Aiguo, Vogt, Stefan, Lai, Barry, Maser, Jörg, Paunesku, Tatjana, Woloschak, Gayle E
Publicado 2007

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

por Munster, P N, Thurn, K T, Thomas, S, Raha, P, Lacevic, M, Miller, A, Melisko, M, Ismail-Khan, R, Rugo, H, Moasser, M, Minton, S E
Publicado 2011